🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

It was a pleasure to attend the training and meet other fellows and AECC team! I am super happy and proud to work in Vall d’Hebron Institute of Oncology (VHIO) Serrano Lab thanks to the AECC Talent programme. Thank you Contra el Cáncer Investigación for making it happen!

#ESMORareCancer25 starting in few hours! Don't miss sessions dedicated to young oncologists! Mentorship, clini starting in a few hours! and clinical cases - all sessionsa with top-level experts! Liz Connolly Herbert Loong, MBBS, FASCO Jean-Yves Blay Kjetil Boye Ray-Coquard Isabelle Alessandro Gronchi ESMO - Eur. Oncology

#ESMORareCancers25: Do not miss the latest scientific findings about #sarcoma and #RareCancers brought to you by the #ESMOAmbassadors & become part of the conversation. #scmsm 📌 ow.ly/tpaR50VletV

Can we identify factors related to risk of recurrence after neoadjuvant imatinib in GIST? - baseline tumor size, change on tx, mitotic index seems to identify high risk group - surprising no benefit of adjuvant tx —> need further validation ESMO - Eur. Oncology #ESMORareCancers25

🚨 Young Oncologists at #ESMORareCancers25 🚨 Today’s Vesalius talk is one not to be missed Unlocking potential: mentorship as a catalyst for success 🙌🏻 Hear from & talk with amazing international experts 🤩 🇫🇷 Ray-Coquard Isabelle 🇮🇹 Alessandro Gronchi 🇺🇸 Sandra P D'Angelo, MD 🇫🇷 Jean-Yves Blay

Kicking off the day 2 of #ESMORareCancer25 with #angiosarcoma session! ‼️great summary of (neo)adjuvant chemotherapy by Stefania Kokkali ESMO - Eur. Oncology Hellenic Group of Sarcomas and rare tumors

💡 Re-irradiation in radiation induced #angiosarcoma 👏 Lisette Wiltink & Rick Haas #ESMORareCancers25 #ESMOAmbassadors

💊 Systemic treatments in advanced #angiosarcoma 🧐 Challenges conducting trials ⬇️ Systemic review by EORTC/ STBSG Eur J Can 2024 Very nice overview by Bernd Kaspar at #ESMORareCancers25 #ESMOAmbassadors

💡 Inspiring session about #TumourAgnostic drug development this morning at #ESMORareCancers2025 📌 Ben Westphalen, ESMO - Eur. Oncology Precision Oncology Task Force Chair, pinpointing the role of ESMO Tumour-Agnostic Classifier and Screener (ETAC-S) on the roadmap of #drugdevelopment 🧵

We have 4 very interesting cases and great experts who will put them in the context of available data and current practice! #ESMORareCancers25 #ESMOAmbassadors

See you in 10 minutes! #ESMORareCancers25

Great start and discussions happening in Hall E about managing advanced #PEComa Andrea Franza, MD & Robin Lewis Jones Roberta Sanfilippo #YO case discussions #ESMORareCancers25 #sarcoma #ESMOAmbassadors

Come join us in #HallE at #ESMORareCancers25 as we discuss very insightful and interesting cases in #PEComa, #ExtraskeletalMyxoidChondrosarcoma amongst many others! Robin Lewis Jones Claudia Verde Liz Connolly Pawel Sobczuk Roberta Sanfilippo

Claudia Valverde & Hailey Carroll expertly taking us through a case of extraskeletal myxoid #chondrosarcoma inc. spontaneous regression Dynamic discussion & great to hear how different centres manage Well done Hailey Carroll 👏 #ESMORareCancers25 #YO case discussion

📣To all breast Young Oncologists! Our Clinical Case discussion is open for submission now! Don’t miss the opportunity to present your clinical case and discuss with experts in person. ESMO - Eur. Oncology Matteo Lambertini, MD PhD Pablo Mando

📢To all CTOS #sarcoma #peeps! The #CommunicationsCommittee wants to know what YOUR preferences are when it comes to #SocialMedia. Please take a couple of minutes to fill this online survey so we can push our #messages and #interact with you in the most efficient &

Save the date: FORTRESS 2026 in Leuven Belgium)! Follow further announcements via kuleuven.be/fortress

Excellent debate at SARC semi-annual meeting pre #ASCO25 on whether neoadjuvant immunotherapy + radiation should now be considered #standardofcare in patients with high grade extremities #STS on the cusp of #SARC32 trial. Always nice to see the #sarcoma community

After the inspiring ASCO meeting we are looking forward to meeting all the sarcoma family again at #CTOS2025! Patient advocacy groups are valuable members of our community! ⬇️Check the invitation from Kathrin Schuster from SPAGN and CTOS Outreach Committee

On #WorldEnvironmentDay, ESMO stands w/ the global community to #BeatPlasticPollution. #Microplastics are found in organs and tumours. More research needed to understand their role in cancer development Pawel Sobczuk 🔗 ow.ly/Q8xT50W3VCP #ESMODailyReporter